Jan Medical to Use Funding for U.S., EU Regulatory Activities
Mountain View, Calif.-based Jan Medical has scooped up $7.5 million in Series C funding from Brainlab for activities related to BrainPulse.
Jan Medical has earmarked the funds for wrapping up clinical trials, as well as submitting a regulatory filing with the FDA and obtaining the CE Mark in the EU for BrainPulse. The device aims to detect abnormal neurological conditions — including concussion and stroke — quickly and accurately.
BrainPulse works by capturing a novel, noninvasive, physiological signal that utilizes the cardiac output to measure vasculature and brain tissue conditions, according to a Jan Medical statement.
Munich, Germany-based Brainlab also has committed to assist with the clinical research, regulatory filings and commercialization activities, as well as provide expertise in R&D. — Elizabeth Hollis